Incyte (INCY) Non-Current Assets (2010 - 2026)

Incyte (INCY) posted Non-Current Assets of $1.9 billion for Q1 2026, down 4.1% on a QoQ basis from $1.9 billion in Q4 2025, and down 17.27% year-over-year from $2.2 billion in Q1 2025.

Incyte (INCY) Non-Current Assets (2010 - 2026) Analysis & Trends

Incyte's Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

  • Quarterly Non-Current Assets fell 17.27% year-over-year to $1.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.0 billion (down 8.31% YoY) and the FY2025 annual result came in at $1.9 billion, down 12.3% from the prior year.
  • Non-Current Assets was $1.9 billion for Q1 2026 at Incyte, down from $1.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.3 billion in Q1 2024 and bottomed at $1.7 billion in Q3 2022.
  • A 5-year average of $2.0 billion and a median of $2.0 billion in 2023 frame the typical range for Non-Current Assets.
  • Annual changes were most pronounced in 2022 — Non-Current Assets jumped 45.78% — and 2026, when it decreased 17.27%.
  • Incyte's Non-Current Assets stood at $1.7 billion in 2022, then rose by 22.23% to $2.1 billion in 2023, then advanced by 3.21% to $2.2 billion in 2024, then retreated by 12.3% to $1.9 billion in 2025, then retreated by 4.1% to $1.9 billion in 2026.
  • Business Quant data shows INCY's Non-Current Assets at $1.9 billion in Q1 2026, $1.9 billion in Q4 2025, and $2.1 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn 1.85 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.85 Bn
Dec 31, 2025 1.93 Bn
Sep 30, 2025 2.05 Bn
Jun 30, 2025 2.18 Bn
Mar 31, 2025 2.24 Bn
Dec 31, 2024 2.21 Bn
Sep 30, 2024 2.20 Bn
Jun 30, 2024 2.09 Bn
Mar 31, 2024 2.29 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 1.99 Bn
Jun 30, 2023 1.94 Bn
Mar 31, 2023 1.83 Bn
Dec 31, 2022 1.75 Bn
Sep 30, 2022 1.69 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 1.77 Bn
Dec 31, 2021 1.81 Bn
Sep 30, 2021 1.28 Bn
Jun 30, 2021 1.28 Bn